ArticleJournal of orthopaedic case reports2026
Novel Application of the AGN1 Triphasic Calcium-Based Implant for a Large Simple Bone Cyst in a Child With 3-Year Follow-up: A Case Report.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Simple bone cysts (SBCs) are benign lesions in children, typically in the proximal humerus. While many are asymptomatic, some necessitate treatment because of impending pathological fractures. Different treatment modalities exist, but no consensus on the best method has been established. Case Report: To the best of our knowledge, this case report describes the first reported clinical application of AGN1 (Ossure™), a CE-marked triphasic calcium-based resorbable implant, in the treatment of a large SBC.A 10-year-old girl with a history of recurrent fractures secondary to a large SBC in the right humerus underwent curettage and AGN1 implantation. The procedure provided immediate stability after implantation and promoted bone healing during the resorption phase. She experienced rapid functional recovery with full mobility in 2 weeks. Early radiographic imaging showed rapid integration at 3 months. Long-term follow-up at nearly 3 years postoperatively confirmed complete resorption of the implant with restoration of normal bone architecture, leaving only a small, asymptomatic residual cyst distally. Conclusion: Current treatments for SBCs, including corticosteroid injections and bone grafting, show varying success rates. AGN1, known for its osteo-enhancing properties in other clinical applications, provided immediate structural support and facilitated rapid bone regeneration with complete resolution of a large SBC in this case.AGN1 may offer a promising alternative for treating large SBCs, especially in patients at high risk of fractures. Its ability to provide early mechanical stability and promote bone regeneration warrants further clinical investigation to assess its use in select cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.